148 related articles for article (PubMed ID: 24769000)
21. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
Jana NR; Nukina N
J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
[TBL] [Abstract][Full Text] [Related]
22. Aging Triggers Cytoplasmic Depletion and Nuclear Translocation of the E3 Ligase Mahogunin: A Function for Ubiquitin in Neuronal Survival.
Benvegnù S; Mateo MI; Palomer E; Jurado-Arjona J; Dotti CG
Mol Cell; 2017 May; 66(3):358-372.e7. PubMed ID: 28475871
[TBL] [Abstract][Full Text] [Related]
23. Quality control of the proteins associated with neurodegenerative diseases.
Gao X; Hu H
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction.
Goswami A; Dikshit P; Mishra A; Mulherkar S; Nukina N; Jana NR
Biochem Biophys Res Commun; 2006 Mar; 342(1):184-90. PubMed ID: 16472774
[TBL] [Abstract][Full Text] [Related]
25. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
26. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
[TBL] [Abstract][Full Text] [Related]
27. [Mechanisms to control degradation of polyglutamine-containing protein].
Nakayama K
Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
[TBL] [Abstract][Full Text] [Related]
28. [Involvement of ubiquitin-proteasome system in polyglutamine disease].
Matsumoto M
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1428-32. PubMed ID: 16922413
[No Abstract] [Full Text] [Related]
29. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
Hatakeyama S
Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
[TBL] [Abstract][Full Text] [Related]
30. Human melanocortin 1 receptor-mediated ubiquitination of nonvisual arrestins. Role of Mahogunin Ring Finger 1 E3 ligase.
Abrisqueta M; Olivares C; Herraiz C; Castejón-Griñán M; Sirés-Campos J; García-Borrón JC; Jiménez-Cervantes C
Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):76-94. PubMed ID: 28947386
[TBL] [Abstract][Full Text] [Related]
31. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
[TBL] [Abstract][Full Text] [Related]
32. Calmodulin regulates MGRN1-GP78 interaction mediated ubiquitin proteasomal degradation system.
Mukherjee R; Bhattacharya A; Sau A; Basu S; Chakrabarti S; Chakrabarti O
FASEB J; 2019 Feb; 33(2):1927-1945. PubMed ID: 30230921
[TBL] [Abstract][Full Text] [Related]
33. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
[TBL] [Abstract][Full Text] [Related]
34. Toll-interacting protein pathway: degradation of an ubiquitin-binding protein.
Shimizu M; Oguro-Ando A; Ohoto-Fujita E; Atomi Y
Methods Enzymol; 2014; 534():323-30. PubMed ID: 24359962
[TBL] [Abstract][Full Text] [Related]
35. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.
Rousseau E; Dehay B; Ben-Haïem L; Trottier Y; Morange M; Bertolotti A
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9648-53. PubMed ID: 15210964
[TBL] [Abstract][Full Text] [Related]
36. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation.
Zhou H; Li SH; Li XJ
J Biol Chem; 2001 Dec; 276(51):48417-24. PubMed ID: 11606565
[TBL] [Abstract][Full Text] [Related]
37. A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein.
Sugiura A; Yonashiro R; Fukuda T; Matsushita N; Nagashima S; Inatome R; Yanagi S
Mitochondrion; 2011 Jan; 11(1):139-46. PubMed ID: 20851218
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Roos RA; van Leeuwen FW
Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742
[TBL] [Abstract][Full Text] [Related]
39. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Mitofusin1 by Mahogunin Ring Finger-1 and the proteasome modulates mitochondrial fusion.
Mukherjee R; Chakrabarti O
Biochim Biophys Acta; 2016 Dec; 1863(12):3065-3083. PubMed ID: 27713096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
